PROCTER & GAMBLE HEALTH | DENIS CHEM LAB | PROCTER & GAMBLE HEALTH/ DENIS CHEM LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 26.5 | 130.7% | View Chart |
P/BV | x | 10.6 | 3.4 | 313.1% | View Chart |
Dividend Yield | % | 2.0 | 1.1 | 176.5% |
PROCTER & GAMBLE HEALTH DENIS CHEM LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
DENIS CHEM LAB Mar-23 |
PROCTER & GAMBLE HEALTH/ DENIS CHEM LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 108 | 4,959.0% | |
Low | Rs | 3,883 | 49 | 7,892.3% | |
Sales per share (Unadj.) | Rs | 740.7 | 115.9 | 639.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | 5.7 | 2,441.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 11.3 | 1,373.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 2.5 | 80.8% | |
Book value per share (Unadj.) | Rs | 447.6 | 52.1 | 859.8% | |
Shares outstanding (eoy) | m | 16.60 | 13.88 | 119.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.7 | 919.4% | |
Avg P/E ratio | x | 33.5 | 13.9 | 240.7% | |
P/CF ratio (eoy) | x | 29.8 | 7.0 | 427.7% | |
Price / Book Value ratio | x | 10.3 | 1.5 | 683.6% | |
Dividend payout | % | 68.7 | 35.3 | 194.6% | |
Avg Mkt Cap | Rs m | 76,761 | 1,092 | 7,028.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 130 | 1,582.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,608 | 764.5% | |
Other income | Rs m | 184 | 6 | 3,106.4% | |
Total revenues | Rs m | 12,480 | 1,614 | 773.0% | |
Gross profit | Rs m | 3,247 | 188 | 1,728.9% | |
Depreciation | Rs m | 281 | 78 | 359.6% | |
Interest | Rs m | 8 | 6 | 120.1% | |
Profit before tax | Rs m | 3,142 | 109 | 2,878.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 31 | 2,772.6% | |
Profit after tax | Rs m | 2,295 | 79 | 2,919.5% | |
Gross profit margin | % | 26.4 | 11.7 | 226.2% | |
Effective tax rate | % | 27.0 | 28.0 | 96.3% | |
Net profit margin | % | 18.7 | 4.9 | 381.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 592 | 1,977.2% | |
Current liabilities | Rs m | 6,791 | 241 | 2,820.7% | |
Net working cap to sales | % | 40.0 | 21.9 | 183.1% | |
Current ratio | x | 1.7 | 2.5 | 70.1% | |
Inventory Days | Days | 263 | 6 | 4,347.8% | |
Debtors Days | Days | 343 | 709 | 48.5% | |
Net fixed assets | Rs m | 10,617 | 402 | 2,640.5% | |
Share capital | Rs m | 166 | 139 | 119.6% | |
"Free" reserves | Rs m | 7,265 | 584 | 1,244.2% | |
Net worth | Rs m | 7,431 | 723 | 1,028.3% | |
Long term debt | Rs m | 0 | 9 | 0.0% | |
Total assets | Rs m | 22,330 | 994 | 2,245.4% | |
Interest coverage | x | 409.1 | 18.0 | 2,268.8% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.6 | 34.0% | |
Return on assets | % | 10.3 | 8.5 | 120.6% | |
Return on equity | % | 30.9 | 10.9 | 283.9% | |
Return on capital | % | 42.4 | 15.8 | 268.4% | |
Exports to sales | % | 0 | 2.0 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 32 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 32 | 4,622.1% | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 32 | -442.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 163 | 1,444.3% | |
From Investments | Rs m | -215 | -112 | 192.7% | |
From Financial Activity | Rs m | -985 | -40 | 2,457.4% | |
Net Cashflow | Rs m | 1,160 | 12 | 9,841.4% |
Indian Promoters | % | 0.0 | 39.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 61.0 | 79.0% | |
Shareholders | 56,778 | 4,834 | 1,174.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | DENIS CHEM LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.51% | 0.45% |
1-Month | -1.15% | 16.18% | 2.55% |
1-Year | 0.73% | 121.01% | 56.14% |
3-Year CAGR | -8.76% | 46.84% | 15.22% |
5-Year CAGR | 4.97% | 22.36% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the DENIS CHEM LAB share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of DENIS CHEM LAB the stake stands at 39.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of DENIS CHEM LAB.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
DENIS CHEM LAB paid Rs 2.0, and its dividend payout ratio stood at 35.3%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of DENIS CHEM LAB.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.